Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation
Gespeichert in:
| Veröffentlicht in: | Blood 2022-11, Vol.140 (Supplement 1), p.7007-7009 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7009 |
|---|---|
| container_issue | Supplement 1 |
| container_start_page | 7007 |
| container_title | Blood |
| container_volume | 140 |
| creator | Quinquenel, Anne Letestu, Rémi Le Garff-Tavernier, Magali Subtil, Fabien Aurran-Schleinitz, Therese Laribi, Kamel Cymbalista, Florence Levy, Vincent Simon, Laurence Roos-Weil, Damien Leblond, Véronique Dilhuydy, Marie-Sarah Dartigeas, Caroline Tomowiak, Cecile Guieze, Romain Tournilhac, Olivier Ferrant, Emmanuelle de Guibert, Sophie Feugier, Pierre Merabet, Fatiha Lepretre, Stephane Carassou, Philippe Gay, Julie Hivert, Bénédicte Fornecker, Luc Mathieu Dupuis, Jehan Molina, Lysiane Villemagne, Bruno Cartron, Guillaume Drenou, Bernard Mahé, Béatrice Benbrahim, Omar Cahu, Xavier Portois, Christelle Ysebaert, Loic Nguyen Khac, Florence Rouille, Valérie Delmer, Alain Michallet, Anne-Sophie |
| description | |
| doi_str_mv | 10.1182/blood-2022-159678 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_159678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122046705</els_id><sourcerecordid>S0006497122046705</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1378-bb22b0536bc489ccc3b49feb4190b40b028a75f0b3ea6925b14c06bce5b9f7293</originalsourceid><addsrcrecordid>eNp9Uctu2zAQJIoUqJP2A3rbY3NQQlKSJSWnQIlTAw5qGEmuAkmvKjYUaZBUUv9pP6d03VMPPe1zdgczhHxm9IKxml9K49w245TzjJXNvKrfkRkreZ1RyukJmVFK51nRVOwDOQ3hB6WsyHk5I7_WHo0etRV-DxsMk4kBXA9xQFho42A9iIDA4dFrYaB3Hp5s9CgibtNChLWIGm0Cvek4wNJG9CNudZrDRocXaAfvrFaw2o-7wal9POQ4veCoBbRu3Amv7XdYSj9FbbWEtZkCPKPF6JQRP-HL8vk81T6k9qLdXP3L8sHZ9JiV8LC5hbtXYabEyNmP5H0vTMBPf-MZeVrcPbZfs9W3-2V7s8oUy6s6k5JzSct8LlVRN0qpXBZNj7JgDZUFlZTXoip7KnMU84aXkhWKpmUsZdNXvMnPCDveVd6F4LHvdl6PSc2O0e5gTffHmu5gTXe0JmGujxhMxF41-i6oJKJKunlUsds6_R_0b1anmh0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Quinquenel, Anne ; Letestu, Rémi ; Le Garff-Tavernier, Magali ; Subtil, Fabien ; Aurran-Schleinitz, Therese ; Laribi, Kamel ; Cymbalista, Florence ; Levy, Vincent ; Simon, Laurence ; Roos-Weil, Damien ; Leblond, Véronique ; Dilhuydy, Marie-Sarah ; Dartigeas, Caroline ; Tomowiak, Cecile ; Guieze, Romain ; Tournilhac, Olivier ; Ferrant, Emmanuelle ; de Guibert, Sophie ; Feugier, Pierre ; Merabet, Fatiha ; Lepretre, Stephane ; Carassou, Philippe ; Gay, Julie ; Hivert, Bénédicte ; Fornecker, Luc Mathieu ; Dupuis, Jehan ; Molina, Lysiane ; Villemagne, Bruno ; Cartron, Guillaume ; Drenou, Bernard ; Mahé, Béatrice ; Benbrahim, Omar ; Cahu, Xavier ; Portois, Christelle ; Ysebaert, Loic ; Nguyen Khac, Florence ; Rouille, Valérie ; Delmer, Alain ; Michallet, Anne-Sophie</creator><creatorcontrib>Quinquenel, Anne ; Letestu, Rémi ; Le Garff-Tavernier, Magali ; Subtil, Fabien ; Aurran-Schleinitz, Therese ; Laribi, Kamel ; Cymbalista, Florence ; Levy, Vincent ; Simon, Laurence ; Roos-Weil, Damien ; Leblond, Véronique ; Dilhuydy, Marie-Sarah ; Dartigeas, Caroline ; Tomowiak, Cecile ; Guieze, Romain ; Tournilhac, Olivier ; Ferrant, Emmanuelle ; de Guibert, Sophie ; Feugier, Pierre ; Merabet, Fatiha ; Lepretre, Stephane ; Carassou, Philippe ; Gay, Julie ; Hivert, Bénédicte ; Fornecker, Luc Mathieu ; Dupuis, Jehan ; Molina, Lysiane ; Villemagne, Bruno ; Cartron, Guillaume ; Drenou, Bernard ; Mahé, Béatrice ; Benbrahim, Omar ; Cahu, Xavier ; Portois, Christelle ; Ysebaert, Loic ; Nguyen Khac, Florence ; Rouille, Valérie ; Delmer, Alain ; Michallet, Anne-Sophie</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-159678</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.7007-7009</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Quinquenel, Anne</creatorcontrib><creatorcontrib>Letestu, Rémi</creatorcontrib><creatorcontrib>Le Garff-Tavernier, Magali</creatorcontrib><creatorcontrib>Subtil, Fabien</creatorcontrib><creatorcontrib>Aurran-Schleinitz, Therese</creatorcontrib><creatorcontrib>Laribi, Kamel</creatorcontrib><creatorcontrib>Cymbalista, Florence</creatorcontrib><creatorcontrib>Levy, Vincent</creatorcontrib><creatorcontrib>Simon, Laurence</creatorcontrib><creatorcontrib>Roos-Weil, Damien</creatorcontrib><creatorcontrib>Leblond, Véronique</creatorcontrib><creatorcontrib>Dilhuydy, Marie-Sarah</creatorcontrib><creatorcontrib>Dartigeas, Caroline</creatorcontrib><creatorcontrib>Tomowiak, Cecile</creatorcontrib><creatorcontrib>Guieze, Romain</creatorcontrib><creatorcontrib>Tournilhac, Olivier</creatorcontrib><creatorcontrib>Ferrant, Emmanuelle</creatorcontrib><creatorcontrib>de Guibert, Sophie</creatorcontrib><creatorcontrib>Feugier, Pierre</creatorcontrib><creatorcontrib>Merabet, Fatiha</creatorcontrib><creatorcontrib>Lepretre, Stephane</creatorcontrib><creatorcontrib>Carassou, Philippe</creatorcontrib><creatorcontrib>Gay, Julie</creatorcontrib><creatorcontrib>Hivert, Bénédicte</creatorcontrib><creatorcontrib>Fornecker, Luc Mathieu</creatorcontrib><creatorcontrib>Dupuis, Jehan</creatorcontrib><creatorcontrib>Molina, Lysiane</creatorcontrib><creatorcontrib>Villemagne, Bruno</creatorcontrib><creatorcontrib>Cartron, Guillaume</creatorcontrib><creatorcontrib>Drenou, Bernard</creatorcontrib><creatorcontrib>Mahé, Béatrice</creatorcontrib><creatorcontrib>Benbrahim, Omar</creatorcontrib><creatorcontrib>Cahu, Xavier</creatorcontrib><creatorcontrib>Portois, Christelle</creatorcontrib><creatorcontrib>Ysebaert, Loic</creatorcontrib><creatorcontrib>Nguyen Khac, Florence</creatorcontrib><creatorcontrib>Rouille, Valérie</creatorcontrib><creatorcontrib>Delmer, Alain</creatorcontrib><creatorcontrib>Michallet, Anne-Sophie</creatorcontrib><title>Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9Uctu2zAQJIoUqJP2A3rbY3NQQlKSJSWnQIlTAw5qGEmuAkmvKjYUaZBUUv9pP6d03VMPPe1zdgczhHxm9IKxml9K49w245TzjJXNvKrfkRkreZ1RyukJmVFK51nRVOwDOQ3hB6WsyHk5I7_WHo0etRV-DxsMk4kBXA9xQFho42A9iIDA4dFrYaB3Hp5s9CgibtNChLWIGm0Cvek4wNJG9CNudZrDRocXaAfvrFaw2o-7wal9POQ4veCoBbRu3Amv7XdYSj9FbbWEtZkCPKPF6JQRP-HL8vk81T6k9qLdXP3L8sHZ9JiV8LC5hbtXYabEyNmP5H0vTMBPf-MZeVrcPbZfs9W3-2V7s8oUy6s6k5JzSct8LlVRN0qpXBZNj7JgDZUFlZTXoip7KnMU84aXkhWKpmUsZdNXvMnPCDveVd6F4LHvdl6PSc2O0e5gTffHmu5gTXe0JmGujxhMxF41-i6oJKJKunlUsds6_R_0b1anmh0</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Quinquenel, Anne</creator><creator>Letestu, Rémi</creator><creator>Le Garff-Tavernier, Magali</creator><creator>Subtil, Fabien</creator><creator>Aurran-Schleinitz, Therese</creator><creator>Laribi, Kamel</creator><creator>Cymbalista, Florence</creator><creator>Levy, Vincent</creator><creator>Simon, Laurence</creator><creator>Roos-Weil, Damien</creator><creator>Leblond, Véronique</creator><creator>Dilhuydy, Marie-Sarah</creator><creator>Dartigeas, Caroline</creator><creator>Tomowiak, Cecile</creator><creator>Guieze, Romain</creator><creator>Tournilhac, Olivier</creator><creator>Ferrant, Emmanuelle</creator><creator>de Guibert, Sophie</creator><creator>Feugier, Pierre</creator><creator>Merabet, Fatiha</creator><creator>Lepretre, Stephane</creator><creator>Carassou, Philippe</creator><creator>Gay, Julie</creator><creator>Hivert, Bénédicte</creator><creator>Fornecker, Luc Mathieu</creator><creator>Dupuis, Jehan</creator><creator>Molina, Lysiane</creator><creator>Villemagne, Bruno</creator><creator>Cartron, Guillaume</creator><creator>Drenou, Bernard</creator><creator>Mahé, Béatrice</creator><creator>Benbrahim, Omar</creator><creator>Cahu, Xavier</creator><creator>Portois, Christelle</creator><creator>Ysebaert, Loic</creator><creator>Nguyen Khac, Florence</creator><creator>Rouille, Valérie</creator><creator>Delmer, Alain</creator><creator>Michallet, Anne-Sophie</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation</title><author>Quinquenel, Anne ; Letestu, Rémi ; Le Garff-Tavernier, Magali ; Subtil, Fabien ; Aurran-Schleinitz, Therese ; Laribi, Kamel ; Cymbalista, Florence ; Levy, Vincent ; Simon, Laurence ; Roos-Weil, Damien ; Leblond, Véronique ; Dilhuydy, Marie-Sarah ; Dartigeas, Caroline ; Tomowiak, Cecile ; Guieze, Romain ; Tournilhac, Olivier ; Ferrant, Emmanuelle ; de Guibert, Sophie ; Feugier, Pierre ; Merabet, Fatiha ; Lepretre, Stephane ; Carassou, Philippe ; Gay, Julie ; Hivert, Bénédicte ; Fornecker, Luc Mathieu ; Dupuis, Jehan ; Molina, Lysiane ; Villemagne, Bruno ; Cartron, Guillaume ; Drenou, Bernard ; Mahé, Béatrice ; Benbrahim, Omar ; Cahu, Xavier ; Portois, Christelle ; Ysebaert, Loic ; Nguyen Khac, Florence ; Rouille, Valérie ; Delmer, Alain ; Michallet, Anne-Sophie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1378-bb22b0536bc489ccc3b49feb4190b40b028a75f0b3ea6925b14c06bce5b9f7293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quinquenel, Anne</creatorcontrib><creatorcontrib>Letestu, Rémi</creatorcontrib><creatorcontrib>Le Garff-Tavernier, Magali</creatorcontrib><creatorcontrib>Subtil, Fabien</creatorcontrib><creatorcontrib>Aurran-Schleinitz, Therese</creatorcontrib><creatorcontrib>Laribi, Kamel</creatorcontrib><creatorcontrib>Cymbalista, Florence</creatorcontrib><creatorcontrib>Levy, Vincent</creatorcontrib><creatorcontrib>Simon, Laurence</creatorcontrib><creatorcontrib>Roos-Weil, Damien</creatorcontrib><creatorcontrib>Leblond, Véronique</creatorcontrib><creatorcontrib>Dilhuydy, Marie-Sarah</creatorcontrib><creatorcontrib>Dartigeas, Caroline</creatorcontrib><creatorcontrib>Tomowiak, Cecile</creatorcontrib><creatorcontrib>Guieze, Romain</creatorcontrib><creatorcontrib>Tournilhac, Olivier</creatorcontrib><creatorcontrib>Ferrant, Emmanuelle</creatorcontrib><creatorcontrib>de Guibert, Sophie</creatorcontrib><creatorcontrib>Feugier, Pierre</creatorcontrib><creatorcontrib>Merabet, Fatiha</creatorcontrib><creatorcontrib>Lepretre, Stephane</creatorcontrib><creatorcontrib>Carassou, Philippe</creatorcontrib><creatorcontrib>Gay, Julie</creatorcontrib><creatorcontrib>Hivert, Bénédicte</creatorcontrib><creatorcontrib>Fornecker, Luc Mathieu</creatorcontrib><creatorcontrib>Dupuis, Jehan</creatorcontrib><creatorcontrib>Molina, Lysiane</creatorcontrib><creatorcontrib>Villemagne, Bruno</creatorcontrib><creatorcontrib>Cartron, Guillaume</creatorcontrib><creatorcontrib>Drenou, Bernard</creatorcontrib><creatorcontrib>Mahé, Béatrice</creatorcontrib><creatorcontrib>Benbrahim, Omar</creatorcontrib><creatorcontrib>Cahu, Xavier</creatorcontrib><creatorcontrib>Portois, Christelle</creatorcontrib><creatorcontrib>Ysebaert, Loic</creatorcontrib><creatorcontrib>Nguyen Khac, Florence</creatorcontrib><creatorcontrib>Rouille, Valérie</creatorcontrib><creatorcontrib>Delmer, Alain</creatorcontrib><creatorcontrib>Michallet, Anne-Sophie</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quinquenel, Anne</au><au>Letestu, Rémi</au><au>Le Garff-Tavernier, Magali</au><au>Subtil, Fabien</au><au>Aurran-Schleinitz, Therese</au><au>Laribi, Kamel</au><au>Cymbalista, Florence</au><au>Levy, Vincent</au><au>Simon, Laurence</au><au>Roos-Weil, Damien</au><au>Leblond, Véronique</au><au>Dilhuydy, Marie-Sarah</au><au>Dartigeas, Caroline</au><au>Tomowiak, Cecile</au><au>Guieze, Romain</au><au>Tournilhac, Olivier</au><au>Ferrant, Emmanuelle</au><au>de Guibert, Sophie</au><au>Feugier, Pierre</au><au>Merabet, Fatiha</au><au>Lepretre, Stephane</au><au>Carassou, Philippe</au><au>Gay, Julie</au><au>Hivert, Bénédicte</au><au>Fornecker, Luc Mathieu</au><au>Dupuis, Jehan</au><au>Molina, Lysiane</au><au>Villemagne, Bruno</au><au>Cartron, Guillaume</au><au>Drenou, Bernard</au><au>Mahé, Béatrice</au><au>Benbrahim, Omar</au><au>Cahu, Xavier</au><au>Portois, Christelle</au><au>Ysebaert, Loic</au><au>Nguyen Khac, Florence</au><au>Rouille, Valérie</au><au>Delmer, Alain</au><au>Michallet, Anne-Sophie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>7007</spage><epage>7009</epage><pages>7007-7009</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-159678</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-4971 |
| ispartof | Blood, 2022-11, Vol.140 (Supplement 1), p.7007-7009 |
| issn | 0006-4971 1528-0020 |
| language | eng |
| recordid | cdi_crossref_primary_10_1182_blood_2022_159678 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T22%3A48%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preliminary%20Results%20of%20the%20Filo%20Phase%202%20Trial%20for%20Untreated%20Fit%20Patients%20with%20Intermediate%20Risk%20Chronic%20Lymphocytic%20Leukemia%20Comparing%20Ibrutinib%20Plus%20Venetoclax%20(IV)%20Versus%20FCR:%20Results%20of%20the%20Month%2015%20MRD%20Evaluation&rft.jtitle=Blood&rft.au=Quinquenel,%20Anne&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=7007&rft.epage=7009&rft.pages=7007-7009&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-159678&rft_dat=%3Celsevier_cross%3ES0006497122046705%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122046705&rfr_iscdi=true |